Barclays’s Innovid Corp. CTV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-163,657
Closed -$506K 5661
2024
Q4
$506K Buy
163,657
+21,235
+15% +$50.1K ﹤0.01% 3809
2024
Q3
$256K Buy
142,422
+105,269
+283% +$191K ﹤0.01% 4166
2024
Q2
$68.7K Sell
37,153
-74,159
-67% -$159K ﹤0.01% 4080
2024
Q1
$277K Sell
111,312
-49,602
-31% -$85.8K ﹤0.01% 3938
2023
Q4
$241K Buy
160,914
+136,327
+554% +$174K ﹤0.01% 4340
2023
Q3
$31.5K Buy
+24,587
New +$28.8K ﹤0.01% 4043
2023
Q2
Sell
-39,875
Closed -$56.2K 5177
2023
Q1
$56.2K Buy
39,875
+19,339
+94% +$35.3K ﹤0.01% 4411
2022
Q4
$35.1K Buy
20,536
+17,293
+533% +$46.8K ﹤0.01% 4668
2022
Q3
$9K Buy
3,243
+2,120
+189% +$6.04K ﹤0.01% 4370
2022
Q2
$2K Buy
+1,123
New +$4.83K ﹤0.01% 4901

Barclays's CTV Position: Q1 2025 in Review

Barclays sold out of Innovid Corp. (CTV) in Q1 2025, closing a stake of 163,657 shares — an estimated $506K sold.

Barclays first reported a position in CTV in Q2 2022 and held it in 10 quarters. The position peaked at $506K in Q4 2024. 0 funds tracked by Wall St. Rank hold CTV as of Q1 2025.

  • Barclays reported no remaining Innovid Corp. position as of Q1 2025 after selling out during the quarter.
  • Barclays sold 163,657 Innovid Corp. shares in Q1 2025, an estimated $506K.
  • Barclays first reported a position in Innovid Corp. in Q2 2022 and held it in 10 quarters.
  • Barclays's Innovid Corp. position peaked at $506K in Q4 2024.
  • 0 funds tracked by Wall St. Rank held Innovid Corp. as of Q1 2025.

Based on Barclays's 13F filing for Q1 2025, filed 15 May 2025.